Wyeth Investors Likely To Win Class Cert. In Pristiq Case

Law360, New York (May 10, 2012, 9:35 PM EDT) -- A New York federal judge on Thursday said he will likely grant class certification to a group of investors who claim Pfizer Inc. unit Wyeth Pharmaceuticals Inc. did not disclose serious side effects associated with the antidepressant Pristiq.

Investors led by a pipe fitters union have asked to go forward as a class in a suit claiming Wyeth, then an independent company, committed securities fraud by failing to disclose heart- and liver-related side effects that appeared during Pristiq's clinical trials.

“I'm going to reserve [judgment] but...
To view the full article, register now.



Case Information

Case Title

City of Livonia Employees' Retirement System v. Essner et al

Case Number



New York Southern

Nature of Suit



Richard J. Sullivan

Date Filed

November 13, 2007

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.